Clinical Trial Update: A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study comparing tirzepatide plus mibavademab versus tirzepatide alone in adults with obesity, with active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Mibavademab
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING